Literature DB >> 18178787

Contrast-induced nephropathy: what are the true clinical consequences?

Michael Rudnick1, Harold Feldman.   

Abstract

BACKGROUND AND OBJECTIVES: Observational studies have demonstrated that short- and long-term mortality is increased in patients who develop contrast-induced nephropathy (CIN). The more clinically relevant questions, and the objectives of this review, are whether CIN is causally related to mortality, and to what extent could mortality in patients undergoing contrast procedures be reduced by preventing CIN. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A literature review was conducted, focusing on observational studies that assessed factors associated with mortality in patients with CIN.
RESULTS: The deaths of some patients with CIN are complicated by factors that cannot be directly related to CIN, such as liver disease, sepsis, respiratory failure, bleeding, etc. However, it is plausible that CIN contributes to cardiovascular causes of death in patients with CIN.
CONCLUSIONS: At the very least, CIN is a marker for increased mortality. More carefully designed prospective studies are needed to fully elucidate the relationship between CIN and death. In the absence of data disproving a causal relationship between CIN and death in all subgroups, reducing its incidence should remain a goal in clinical practice as well as a target for future research.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18178787     DOI: 10.2215/CJN.03690907

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  32 in total

Review 1.  Contrast-induced nephropathy in CT: incidence, risk factors and strategies for prevention.

Authors:  Shu Min Tao; Julian L Wichmann; U Joseph Schoepf; Stephen R Fuller; Guang Ming Lu; Long Jiang Zhang
Journal:  Eur Radiol       Date:  2015-12-18       Impact factor: 5.315

Review 2.  Contrast-induced acute kidney injury and diabetic nephropathy.

Authors:  Andrew D Calvin; Sanjay Misra; Axel Pflueger
Journal:  Nat Rev Nephrol       Date:  2010-09-28       Impact factor: 28.314

3.  Nephrotoxicity of gadolinium-based contrast in the setting of renal artery intervention: retrospective analysis with 10-year follow-up.

Authors:  Edwin A Takahashi; David F Kallmes; Kristin C Mara; William S Harmsen; Sanjay Misra
Journal:  Diagn Interv Radiol       Date:  2018-11       Impact factor: 2.630

4.  Incidence of persistent renal dysfunction after contrast enhanced coronary CT angiography in patients with suspected coronary artery disease.

Authors:  Teemu Maaniitty; Iida Stenström; Valtteri Uusitalo; Heikki Ukkonen; Sami Kajander; Jeroen J Bax; Antti Saraste; Juhani Knuuti
Journal:  Int J Cardiovasc Imaging       Date:  2016-07-12       Impact factor: 2.357

5.  Incidence of contrast-induced acute kidney injury in a pediatric setting: a cohort study.

Authors:  Aymeric Cantais; Zeineb Hammouda; Olivier Mory; Hugues Patural; Jean-Louis Stephan; Lyudmyla Gulyaeva; Michael Darmon
Journal:  Pediatr Nephrol       Date:  2016-03-21       Impact factor: 3.714

Review 6.  Prevention of Contrast and Radiation Injury During Coronary Angiography and Percutaneous Coronary Intervention.

Authors:  Arash Ehteshami Afshar; Puja B Parikh
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-03-22

Review 7.  Renal imaging in patients with renal impairment.

Authors:  Jason A Poff; Elizabeth M Hecht; Parvati Ramchandani
Journal:  Curr Urol Rep       Date:  2011-02       Impact factor: 3.092

8.  The RIP1-kinase inhibitor necrostatin-1 prevents osmotic nephrosis and contrast-induced AKI in mice.

Authors:  Andreas Linkermann; Jan-Ole Heller; Agnes Prókai; Joel M Weinberg; Federica De Zen; Nina Himmerkus; Attila J Szabó; Jan H Bräsen; Ulrich Kunzendorf; Stefan Krautwald
Journal:  J Am Soc Nephrol       Date:  2013-07-05       Impact factor: 10.121

9.  Incidence of contrast-induced nephropathy after contrast-enhanced computed tomography in the outpatient setting.

Authors:  Alice M Mitchell; Alan E Jones; James A Tumlin; Jeffrey A Kline
Journal:  Clin J Am Soc Nephrol       Date:  2009-12-03       Impact factor: 8.237

10.  Sodium bicarbonate for the prevention of contrast-induced nephropathy: a meta-analysis of 17 randomized trials.

Authors:  Mehmet Kanbay; Adrian Covic; Steven G Coca; Faruk Turgut; Ali Akcay; Chirag R Parikh
Journal:  Int Urol Nephrol       Date:  2009-04-25       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.